Literature DB >> 24064000

Dissimilar cytokine patterns in different human liver and colon cancer cell lines.

Eliana Guerriero1, Francesca Capone, Fabiola Rusolo, Giovanni Colonna, Giuseppe Castello, Susan Costantini.   

Abstract

An accurate and simultaneous estimate of cellular levels of a large cytokine number is very useful to obtain information about an organ dysfunction leading to cancer because through the understanding of the evolution of cytokine patterns we can recognize and predict the disease progression. Cancer cell lines are commonly used to study the cancer microenvironment, to analyze their chemosensitivity and carcinogenesis as well as to test in vitro the effect of molecules, such as drugs or anti-oxidants, on the inflammation status and its progression. We noted that various cell lines commonly used as a model for studies on liver and colon cancer possess different patterns of cytokines. This aspect may generate data not comparable in laboratories using different cell lines; thus, to investigate the origin of these abnormalities we compared the cell lines HepG2 and Huh7, and HT-29 and HCT-116, for liver and colon cancer, respectively. In this context we have evaluated and compared the levels of cytokines, chemokines and growth factors in the supernatants of these cellular lines. Our aim was to identify what cytokines were significantly different correlating similarities and differences to the specific inflammation status of each cellular model of cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer cell lines; Chemokines; Cytokines; Growth factors; Multiplex immunoassay

Mesh:

Substances:

Year:  2013        PMID: 24064000     DOI: 10.1016/j.cyto.2013.09.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  3 in total

1.  Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.

Authors:  Laura Patras; Bianca Sylvester; Lavinia Luput; Alina Sesarman; Emilia Licarete; Alina Porfire; Dana Muntean; Denise Minerva Drotar; Alexandra Doina Rusu; Andras-Laszlo Nagy; Cornel Catoi; Ioan Tomuta; Laurian Vlase; Manuela Banciu; Marcela Achim
Journal:  Cancer Biol Ther       Date:  2017-07-11       Impact factor: 4.742

Review 2.  Involvement of inflammation and its related microRNAs in hepatocellular carcinoma.

Authors:  Ke Jin; Tong Li; Gonzalo Sánchez-Duffhues; Fangfang Zhou; Long Zhang
Journal:  Oncotarget       Date:  2017-03-28

3.  The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes.

Authors:  Francesca Capone; Eliana Guerriero; Giovanni Colonna; Patrizia Maio; Alessandra Mangia; Raffaele Marfella; Giuseppe Paolisso; Francesco Izzo; Nicoletta Potenza; Luigi Tomeo; Giuseppe Castello; Susan Costantini
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.